Therapeutic challenges at the preclinical level for targeted drug development for Opisthorchis viverrini-associated cholangiocarcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Therapeutic challenges at the preclinical level for targeted drug development for Opisthorchis viverrini-associated cholangiocarcinoma

Published:2021-07-22 Issue:9 Volume:30 Page:985-1006
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

Loilome Watcharin¹²³^ORCID,Dokduang Hasaya²³,Suksawat Manida¹²³,Padthaisong Sureerat¹²³

Affiliation:

1. Department of Biochemistry, Faculty of Medicine, Khon Kaen University, Khon Kaen Thailand

2. Cholangiocarcinoma Screening and Care Program (CASCAP), Khon Kaen University, Khon Kaen, Thailand

3. Cholangiocarcinoma Research Institute, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand

Funder

National Research Council

Fund of Khon Kaen University

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543784.2021.1955102

Reference230 articles.

1. Cholangiocarcinoma 2020: the next horizon in mechanisms and management

2. Cancer review: Cholangiocarcinoma

3. Inflammation and Progression of Cholangiocarcinoma: Role of Angiogenic and Lymphangiogenic Mechanisms

4. Cholangiocarcinoma: Epidemiology and risk factors

5. Oxidative and nitrative DNA damage: Key events in opisthorchiasis-induced carcinogenesis

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The potential use of natural products as sources of bioactive compounds: Searching for new treatments for neglected tropical diseases;Studies in Natural Products Chemistry;2024

2. Immune microenvironment and progress in immunotherapy of cholangiocarcinoma;Clinical Immunology Communications;2023-12

3. Opisthorchis viverrini—Current Understanding of the Neglected Hepatobiliary Parasite;Pathogens;2023-06-02

4. Human microbiomes in cancer development and therapy;MedComm;2023-02-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3